ORIGINAL ARTICLES
Nebulized lidocaine in the treatment of severe asthma in children: a pilot study

https://doi.org/10.1016/S1081-1206(10)62656-7Get rights and content

Background

Glucocorticoids have been used to treat asthma since the 1950s; however, their adverse systemic effects have limited their duration of use and dosage. Unfortunately, many patients with severe asthma often require oral glucocorticoids in addition to inhaled glucocorticoids. Alternatives to glucocorticoids have been sought with mixed success. Recently, lidocaine has been added to the list of potent glucocorticoid sparing agents for the treatment of severe asthma.

Objective

We report the first group of pediatric patients with severe asthma treated with nebulized lidocaine.

Methods

The study was performed in an open manner with 6 severely asthmatic patients followed in the Pediatric Allergy and Immunology Section, Mayo Clinic. The only intervention was the institution of nebulized lidocaine (0.8 mg/kg/dose to 2.5 mg/kg/dose tid to qid). The average daily steroid requirement was followed during the administration of the nebulized lidocaine.

Results

During a mean of 11.2 months of therapy (range 7 to 16 months) 5 of the 6 patients completely discontinued their oral glucocorticoids within an average time of 3.4 months (range 1 to 7 months).

Conclusions

After further study, lidocaine may prove to be the first non-toxic, steroid alternative to patients with severe steroid-dependent asthma.

REFERENCES (17)

  • LW Hunt et al.

    Effect of nebulized lidocaine on severe glucocorticoid-dependent asthma

    Mayo ClinProc

    (1996)
  • C Teale et al.

    Local anaesthesia for fiberoptic bronchoscopy: comparison between intratracheal cocaine and lignocaine

    Respir Med

    (1990)
  • HM Carryer et al.

    The effect of cortisone on bronchial asthma and hayfever occurring in subjects sensitive to ragweed pollen

    Mayo Clin Proc

    (1950)
  • RC Haynes

    Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs, inhibitors of the synthesis and actions of adrenocortical hormones

  • N Wallen et al.

    Glucocorticoids inhibit cytokine-mediated eosinophil survival

    J Immunol

    (1991)
  • American Thoracic Society

    Chronic bronchitis, asthma, and pulmonary emphysema: a statement by the Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases

    Am Rev Respir Dis

    (1962)
  • I Augstkalns et al.

    The value of topical lignocaine for bronchoscopy under general anesthesia

    Anaesthesia

    (1977)
  • RJ Ayella

    Practical anesthesia for bronchography

    Radiology

    (1973)
There are more references available in the full text version of this article.

Cited by (0)

The work submitted was supported by the Mayo Foundation.

View full text